Fundraising FoxAsabys Partners — 2021 Investments
1 investments dated 2021 · listed companies and verified rows first · show all
binx health develops FDA-cleared, CLIA-waived point-of-care diagnostic testing for chlamydia and gonorrhea in male and female patients, delivering central-lab-quality results in about thirty minutes so patients can test, get diagnosed, and receive treatment in one visit.
BiotechDigital HealthHealthtechMedical DevicesTrowbridge
Anna Dixon(Executive Officer)inMarc Jones(Executive Officer)inJeffrey R. Luber(Executive Officer, Director)in
BoardAndrew Goldman(Director)Martin Munchbach(Director)Jihua Wang(Director)
Co-investorsOrbiMed
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.